Page last updated: 2024-10-28

gyki 52466 and Vasospasm, Intracranial

gyki 52466 has been researched along with Vasospasm, Intracranial in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).

Research Excerpts

ExcerptRelevanceReference
"The pathogenesis and treatment of cerebral vasospasm (CV) after subarachnoid hemorrhage (SAH) remains a matter of discussion."1.35Effects of GYKI 52466 on early vasospasm in rats. ( Akdemir, O; Colak, A; Karaoglan, A; Kokturk, S; Sagmanligil, A; Soy, O; Tasyurekli, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colak, A1
Soy, O1
Karaoglan, A1
Akdemir, O1
Kokturk, S1
Sagmanligil, A1
Tasyurekli, M1

Other Studies

1 other study available for gyki 52466 and Vasospasm, Intracranial

ArticleYear
Effects of GYKI 52466 on early vasospasm in rats.
    Central European neurosurgery, 2009, Volume: 70, Issue:4

    Topics: Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Femoral Artery; Microscopy, Electron, T

2009